Omic approaches to pediatric bone sarcomas
- PMID: 31736201
- DOI: 10.1002/pbc.28072
Omic approaches to pediatric bone sarcomas
Abstract
Over the last decade, next-generation sequencing technologies have improved our ability to assess biological aspects, at genomic and transcriptomic levels, on a large scale- and have been increasingly used for the management of adult cancers. However, their efficacy and feasibility within pediatrics is still under investigation. "Omic" approaches represent an opportunity to understand the oncogenic mechanisms driving the onset and progression of bone sarcoma and improve the clinical management of young patients with bone sarcomas. This review focuses on the current genomic and transcriptomic characteristics of managing pediatric patients, affected by Ewing sarcoma and osteosarcoma.
Keywords: Ewing sarcoma; genomic; next-generation sequencing; osteosarcoma; pediatric oncology; transcriptomic.
© 2019 Wiley Periodicals, Inc.
References
REFERENCES
-
- Choi EY, Gardner JM, Lucas DR, McHugh JB, Patel RM. Ewing sarcoma. Semin Diagn Pathol. 2014;31(2014):39-47.
-
- Tirtei E, Asaftei SD, Manicone R, et al. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis. Tumori. 2018;104(3):202-206.
-
- Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13(8):480-491.
-
- Forrest SJ, Geoerger B, Janeway KA. Precision medicine in pediatric oncology. Curr Opin Pediatr. 2018;30(1):17-24.
-
- Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18(1):83.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
